Ozempic and Stomach Paralysis (Gastroparesis) Research suggests that Ozempic and other GLP-1 receptor agonists may substantially increase a persons risk of developing gastroparesis or stomach paralysis
These increases are offset by a decrease in toxicology costs of $2,738,000 as a result of IND-enabling studies completed in the prior year for inclusion in the CRB-601 IND filing and a decrease in compensation costs of $1,328,000 as a result of reduced headcount
An alternative explanation, which could potentially explain both sets of experiments, is that exported GSH is broken down into constituent amino acids in the blood that are rapidly reimported into the liver cells
However, there have been concerns regarding using glutathione IV therapy for skin lightening
The physiological effects of supplementation are more pronounced in older versus younger individuals [82], but do not consistently differ between diet groups [97], suggesting that dietary creatine is not influential for physical performance [98]
GSTM, GSTP, and GST are gene mutations where you have a decreased ability to conjugate glutathione
